Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN3QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,558
Award facts
- Contract value 100% obligated
- $2,558.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,558.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injectors. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling value through December 2026. The delivery order is non-set-aside and was competitively awarded. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of August 6, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its prime indefinite delivery contract with the Defense Logistics Agency's Troop Support Medical division. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical devices. This delivery order for testosterone replacement therapy auto-injectors reflects the company's ongoing role in supporting Defense Health Agency and other federal healthcare system requirements for pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FN3QN?
SPE2DB25FN3QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FN3QN worth?
The government has obligated $2,558 on SPE2DB25FN3QN.
Is contract SPE2DB25FN3QN an order under another contract?
Yes. SPE2DB25FN3QN is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3QN competed?
The extent of competition for SPE2DB25FN3QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award